<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="other"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Indian J Ophthalmol</journal-id><journal-id journal-id-type="publisher-id">Indian Journal of Ophthalmology</journal-id><journal-title-group><journal-title>Indian Journal of Ophthalmology</journal-title></journal-title-group><issn pub-type="ppub">0301-4738</issn><issn pub-type="epub">1998-3689</issn><publisher><publisher-name>Medknow Publications</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">18158406</article-id><article-id pub-id-type="pmc">2636064</article-id><article-id pub-id-type="publisher-id">IndianJOphthalmol_2008_56_1_63_37598</article-id><article-categories><subj-group subj-group-type="heading"><subject>Brief Report</subject></subj-group></article-categories><title-group><article-title>Pupil dilation with intracameral lidocaine during phacoemulsification: Benefits for the patient and surgeon</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Nikeghbali</surname><given-names>Aminollah</given-names></name><degrees>MD</degrees></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Falavarjani</surname><given-names>Khalil Ghasemi</given-names></name><degrees>MD</degrees></contrib><contrib contrib-type="author"><name><surname>Kheirkhah</surname><given-names>Ahmad</given-names></name><degrees>MD</degrees></contrib></contrib-group><aff>Eye Research Center, Iran University of Medical Science, Tehran, Iran</aff><author-notes><corresp id="cor1">Correspondence to Dr. Khalil Ghasemi Falavarjani, Eye Research Center,Rasool Akram Hospital, Satt arkhan-Niayesh Street, Tehran 14455-364,Iran. Email: <email>drghasemi@yahoo.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Jan-Feb</season><year>2008</year></pub-date><volume>56</volume><issue>1</issue><fpage>63</fpage><lpage>64</lpage><history><date date-type="received"><day>14</day><month>5</month><year>2006</year></date><date date-type="accepted"><day>31</day><month>3</month><year>2007</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; Indian Journal of Ophthalmology</copyright-statement><copyright-year>2008</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Topical and/or intracameral administration of anticholinergicand/or sympathomimetic mydriatic agents which are usuallyused for pupillary dilation during cataract surgery, have somedisadvantages such as slow onset of dilation and adverse ocularand systemic effects. We evaluated intracameral injection ofpreservative-free 1% lidocaine without using any preoperativeor intraoperative mydriatics to induce pupil dilation in 31consecutive eyes scheduled for phacoemulsification cataractextraction and intraocular lens implantation. Pupil diameterwas measured before and 90 sec after intracameral lidocaineinjection. After intracameral lidocaine injection, the mean pupildiameter was significantly greater than the baseline measurement(<italic>P</italic>&#x0003c;0.001). No additional mydriatics were needed up to the end ofthe operations. Intracameral preservative-free lidocaine 1% has arapid and effective mydriasis that could be a safe alternative totopical and intracameral mydriatics in phacoemulsification.</p></abstract><kwd-group><kwd>Intracameral lidocaine</kwd><kwd>phacoemulsification</kwd><kwd>pupil dilation</kwd></kwd-group></article-meta></front><body><p>Cataract surgery requires adequate mydriasis, which is usuallyachieved by topical and/or intracameral administration ofanticholinergic and/or sympathomimetic mydriatic agents,commonly cyclopentolate, tropicamide and phenylephrine.<xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref2">2</xref></p><p>These regimens, however, have some disadvantages such asslow onset of dilation, which increases the waiting time beforeoperation,<xref ref-type="bibr" rid="ref2">2</xref>,<xref ref-type="bibr" rid="ref3">3</xref> adverse ocular and systemic effects, which arespecially important in high-risk groups such as hypertensivepatients and children <xref ref-type="bibr" rid="ref2">2</xref>-<xref ref-type="bibr" rid="ref5">5</xref> and their tendencies to wear off duringsurgery.<xref ref-type="bibr" rid="ref2">2</xref></p><p>Intracameral injection of preservative-free lidocainewas attempted as an alternative to reduce the potentialdisadvantages of common mydriatics.<xref ref-type="bibr" rid="ref6">6</xref><xref ref-type="bibr" rid="ref7">7</xref> We evaluated usingintracameral injection of preservative-free lidocaine to inducepupil dilation, without using any preoperative dilating eyedrops or intraoperative mydriatics.</p><sec sec-type="materials|methods"><title>Materials and Methods</title><p>This prospective interventional case series included patientswith senile cataracts scheduled for phacoemulsification andintraocular lens (IOL) implantation. For cataract grading, wematched the color and opalescence of the patient&#x02032;s lens on theslit-lamp examination with the standard photographs of LensOpacities Classification System III.<xref ref-type="bibr" rid="ref8">8</xref> The patients with anyvisible iris abnormality due to any cause were excluded fromthe study. The Institutional Review Board of the Iran Universityof Medical Sciences approved the study and all patients signedan informed consent.</p><p>All patients were given three drops of tetracaine 1%five min before surgery. All procedures and measurementswere performed by one surgeon (AN). After creation of aparacentesis, 0.2 to 0.3 ml of preservative-free lidocaine 1%was injected into the anterior chamber. A quick chop method<xref ref-type="bibr" rid="ref9">9</xref>was performed using Millennium phacoemulsifier (Bausch andLomb, NY, USA), hydroxypropyl methylcellulose 2% (Bauschand Lomb, Waterford, Ireland) as a viscoelastic agent, balancedsalt solution (BSS&#x000ae;) as irrigation solution and one-piece foldableIOL (Acrysof&#x000ae;, Alcon laboratories inc, Fort Worth, TX, USA) inthe bag implantation. There was no epinephrine added to theirrigating solution.</p><p>Before lidocaine injection, the horizontal diameter of the pupilwas measured with a caliper under the operating microscopelight. The light intensity of the microscope was the same duringmeasurements and throughout all procedures. Pupil diameterwas measured again within 90 sec after intracameral lidocaineinjection, when the surgeon was able to proceed for needlecapsulorrhexis. All measurements were taken on the surface ofthe cornea and no magnification correction was made to knowthe actual size of the pupil. Total surgical time was measuredfrom the time of first stab incision to the end of operation whenthe blepharostat was removed.</p><p>Data were analyzed using SPSS for Windows Version 11(SPSS, Chicago, Illinois, USA).</p></sec><sec><title>Results</title><p>Sixteen males and 15 females with a mean age of 67.3&#x000b1;9.9years were included in the study. There were four diabeticand four pseudoexfoliative eyes. All the patients had brownirides. Included eyes had nuclear opalescence and nuclearcolor  &#x02265; Grade 4 (range 4 to 6) with variable amounts of corticaland posterior subcapsular cataracts. None of the patients hadmature cataract.</p><p>The mean pupil diameter after intracameral lidocaine wassignificantly greater than the baseline pupil size [<xref ref-type="table" rid="T1">Table 1</xref>]. Themean increase in pupil size was 4.39&#x000b1;0.53 mm. There was nosignificant difference between the average male and female pupildiameters and between the average pupil size of diabetic andnon-diabetic patients, both at baseline and after intracamerallidocaine injection measurements (independent t test). Atbaseline there was no significant difference between averagepupil diameter in patients with pseudoexfoliation (2.66 mm) andthose without (2.47 mm). However, after intracameral lidocaineinjection, the average pupil diameter was significantly greaterfor patients without pseudoexfoliation (7.1 mm vs. 6.00 mm,Independent t test and Mann-Whitney test, <italic>P</italic>&#x0003c;0.01). The meansurgical time was 11.67&#x000b1; 3.05 min.</p><p>The pupil dilation was satisfactory, persistent and stableup to the end of the surgery. One patient developed posteriorcapsular tear with vitreous loss at the time of cortical materialremoval that was managed properly with an IOL in the ciliarysulcus, without the need for additional mydriatics.</p></sec><sec><title>Discussion</title><p>Lidocaine is an antiarrhythmic drug as well as an effective localanesthetic. Intracameral injection of preservative-free lidocaineis used widely for local anesthesia and discomfort relief incataract surgery.<xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref10">10</xref> Lidocaine causes no additional inflammationand endothelial cell loss and its safety has been confirmed inprevious studies.<xref ref-type="bibr" rid="ref11">11</xref>-<xref ref-type="bibr" rid="ref14">14</xref></p><p>Lincoff <italic>et al</italic>. reported the effect of lidocaine on iris paralysisand mydriasis.<xref ref-type="bibr" rid="ref15">15</xref> They noted pupil dilation after accidentalintraocular injection of lidocaine without administration of anymydriatic drug. Lee <italic>et al</italic>. reported immediate pupil dilationafter intracameral injection of preservative-free lidocaine 1%in previously undilated phakic eyes during trabeculectomysurgery.<xref ref-type="bibr" rid="ref6">6</xref> Cionni <italic>et al</italic>. used intracameral lidocaine injection toinduce mydriasis in phacoemulsification surgery, avoidingall preoperative dilating eye drops.<xref ref-type="bibr" rid="ref7">7</xref> However, in their report,epinephrine has been added to the infusion during routineprocedure to maintain pupil dilation.<xref ref-type="bibr" rid="ref7">7</xref></p><p>This study shows that injection of 0.2 to 0.3 ml of 1%preservative-free lidocaine in anterior chamber can have apersistent, stable and satisfactory pupil dilation for a safephacoemulsification and IOL implantation in differentpatients including diabetic and non-diabetic and eyes withpseudoexfoliation. In the present study, despite the fact thatno additional mydriatic drug has been used in infusion fluid,the pupil was adequately maintained dilated during theprocedure.</p><p>Intracameral lidocaine has some advantages over topicalmydriatics. It doesn&#x02032;t need time-consuming preoperativeprogram for pupillary dilation, doesn&#x02032;t have systemicside-effects of topical mydriatics and provides satisfactorypupillary dilation as well as simultaneous anesthetic effect inphacoemulsification cataract surgery.</p><p>This study has some limitations. We measured the pupillarydiameters on the surface of the cornea and did not consider themagnification factor of cornea to calculate the actual pupillarydiameters. In this study, the usual operating time was 8 to 15min. However, it is not clear how long the pupillary dilationwill last after an intracameral lidocaine injection. Although inthe sole complicated case of this study, the pupil maintainedits dilation up to the end of 25 min of the operation this couldnot be generalized. Future studies are recommended tostudy the permanence of pupillary dilation after intracamerallidocaine injection as compared to the topical and intracameralmydriatics. We conclude that intracameral lidocaine is a safeand efficient alternative to traditional topical and intracameralmydriatics during phacoemulsification surgery.</p></sec></body><back><ref-list><ref id="ref1"><label>1</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hejny</surname><given-names>C</given-names></name><name><surname>Edelhauser</surname><given-names>HF</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Buratto</surname><given-names>L</given-names></name><name><surname>Werner</surname><given-names>L</given-names></name><name><surname>Zanini</surname><given-names>M</given-names></name><name><surname>Apple</surname><given-names>D</given-names></name></person-group><article-title>Surgical pharmacology: Intraocular solutions and drugs used for cataract surgery</article-title><source>Phacoemulsification; Principle and Techniques.</source><year>2003</year><publisher-loc>Thorofare, NJ</publisher-loc><publisher-name>Slack</publisher-name><fpage>219</fpage><lpage>46</lpage></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lundberg</surname><given-names>B</given-names></name><name><surname>Behndig</surname><given-names>A</given-names></name></person-group><article-title>Intracameral mydriatics in phacoemulsification cataract surgery</article-title><source>J Cataract Refract Surg</source><year>2003</year><volume>29</volume><fpage>2366</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">14709298</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lovastik</surname><given-names>JV</given-names></name></person-group><article-title>Pharmacokinetics of topically applied cyclopentolate HCl and tropicamide</article-title><source>Am J Optom Physiol Opt</source><year>1986</year><volume>63</volume><fpage>787</fpage><lpage>803</lpage><pub-id pub-id-type="pmid">3777109</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fraunfelder</surname><given-names>FT</given-names></name><name><surname>Safidi</surname><given-names>AF</given-names></name></person-group><article-title>Possible adverse effects from topical ocular 10% phenylephrine</article-title><source>Am J Ophthalmol</source><year>1978</year><volume>85</volume><fpage>447</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">655224</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogut</surname><given-names>MS</given-names></name><name><surname>Bozkurt</surname><given-names>N</given-names></name><name><surname>Ozek</surname><given-names>E</given-names></name><name><surname>Birgen</surname><given-names>H</given-names></name><name><surname>Kazokoglu</surname><given-names>H</given-names></name><name><surname>Ogut</surname><given-names>M</given-names></name></person-group><article-title>Effects and side effects of mydriatic eye drops in neonates</article-title><source>Eur J Ophthalmol</source><year>1996</year><volume>6</volume><fpage>192</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">8823596</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JJ</given-names></name><name><surname>Moster</surname><given-names>MR</given-names></name><name><surname>Henderer</surname><given-names>JD</given-names></name><name><surname>Membreno</surname><given-names>JH</given-names></name></person-group><article-title>Pupil dilation with intracameral 1% lidocaine during glaucoma filtering surgery</article-title><source>Am J Ophthalmol</source><year>2003</year><volume>136</volume><fpage>201</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">12834699</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cionni</surname><given-names>RJ</given-names></name><name><surname>Barros</surname><given-names>MG</given-names></name><name><surname>Kaufman</surname><given-names>AH</given-names></name><name><surname>Osher</surname><given-names>RH</given-names></name></person-group><article-title>Cataract surgery without preoperative eyedrops</article-title><source>J Cataract Refract Surg</source><year>2003</year><volume>29</volume><fpage>2281</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">14709286</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chylack</surname><given-names>LT</given-names><suffix>Jr</suffix></name><name><surname>Wolfe</surname><given-names>JK</given-names></name><name><surname>Singer</surname><given-names>DM</given-names></name><name><surname>Leske</surname><given-names>MC</given-names></name><name><surname>Bullimore</surname><given-names>MA</given-names></name><name><surname>Bailey</surname><given-names>IL</given-names></name><etal/></person-group><article-title>The lens opacities classification system III</article-title><source>Arch Ophthalmol</source><year>1993</year><volume>111</volume><fpage>831</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">8512486</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Steinert</surname><given-names>RF</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Steinert</surname><given-names>RF</given-names></name></person-group><article-title>Phaco chop</article-title><source>Cataract surgery: Techniques, complications and management</source><year>2004</year><edition>2nd ed</edition><publisher-loc>Philadelphia</publisher-loc><publisher-name>Saunders</publisher-name><fpage>183</fpage><lpage>91</lpage></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gills</surname><given-names>JP</given-names></name><name><surname>Cherchio</surname><given-names>M</given-names></name><name><surname>Raanan</surname><given-names>MG</given-names></name></person-group><article-title>Unpreserved lidocaine to control discomfort during cataract surgery using topical anesthesia</article-title><source>J Cataract Refract Surg</source><year>1997</year><volume>23</volume><fpage>545</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">9209989</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weller</surname><given-names>A</given-names></name><name><surname>Pham</surname><given-names>DT</given-names></name><name><surname>Haberle</surname><given-names>H</given-names></name></person-group><article-title>Intracameral anesthesia with lidocaine in cornea guttata</article-title><source>Ophthalmologe</source><year>2002</year><volume>99</volume><fpage>29</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">11840792</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia</surname><given-names>A</given-names></name><name><surname>Loureiro</surname><given-names>F</given-names></name><name><surname>Limao</surname><given-names>A</given-names></name><name><surname>Sampaio</surname><given-names>A</given-names></name><name><surname>Ilharco</surname><given-names>J</given-names></name></person-group><article-title>Preservative-free lidocaine 1% anterior chamber irrigation as an adjunct to topical anesthesia</article-title><source>J Cataract Refract Surg</source><year>1998</year><volume>24</volume><fpage>403</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">9580374</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eggeling</surname><given-names>P</given-names></name><name><surname>Pleyer</surname><given-names>U</given-names></name><name><surname>Hartmann</surname><given-names>C</given-names></name><name><surname>Rieck</surname><given-names>PW</given-names></name></person-group><article-title>Corneal endothelial toxicity of different lidocaine concentrations</article-title><source>J Cataract Refract Surg</source><year>2000</year><volume>26</volume><fpage>1403</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">11020627</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iradier</surname><given-names>MT</given-names></name><name><surname>Fernandez</surname><given-names>C</given-names></name><name><surname>Bohorquez</surname><given-names>P</given-names></name><name><surname>Moreno</surname><given-names>E</given-names></name><name><surname>del Castillo</surname><given-names>JB</given-names></name><name><surname>Garcia</surname><given-names>J</given-names></name></person-group><article-title>Intraocular lidocaine in phacoemulsification: An endothelium and blood-aqueous barrier permeability study</article-title><source>Ophthalmology</source><year>2000</year><volume>107</volume><fpage>896</fpage><lpage>901</lpage><pub-id pub-id-type="pmid">10811081</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lincoff</surname><given-names>H</given-names></name><name><surname>Zweifach</surname><given-names>P</given-names></name><name><surname>Brodie</surname><given-names>S</given-names></name><name><surname>Fuchs</surname><given-names>W</given-names></name><name><surname>Gross</surname><given-names>S</given-names></name><name><surname>Kornmehl</surname><given-names>E</given-names></name><etal/></person-group><article-title>Intraocular injection of lidocaine</article-title><source>Ophthalmology</source><year>1985</year><volume>92</volume><fpage>1587</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">4080331</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Mean pupil diameters (in mm) in patients whounderwent phacoemulsification with intracameral injectionof lidocaine for pupillary dilation</p></caption><alt-text>Table 1</alt-text><graphic xlink:href="IndianJOphthalmol-56-63-g001"/></table-wrap></floats-group></article>